Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Sparta Surgical

This article was originally published in The Gray Sheet

Executive Summary

Acquisition of ICS of North America for $5.6 mil. -including $3.5 mil. in common stock, $1 mil. in cash, a $500,000 note, and assumption of $600,000 in liabilities - is outlined in a non-binding letter of intent agreement, announced March 8. The letter of intent also calls for Sparta to issue "earn-out common shares" and cash payments to ICS's principals, in the event ICS' business meets certain net sales and net income goals beginning the fiscal year ending Feb. 29, 2000. The privately held, San Diego-based digital monitoring technology firm ICS had 1998 revenues of about $5 mil

Latest Headlines
See All
UsernamePublicRestriction

Register

MT011482

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel